verified SJR 0,699 · Q1 • database Scopus / SJR & DOAJ indexed

New Zealand · Dove Medical Press Ltd

workspace_premium Q1 — Medicine (miscellaneous) visibility_off Single blind Peer Review lock_open Open Access · DOAJ Unclaimed

Therapeutics and Clinical Risk Management

Therapeutics and Clinical Risk Management is a journal indexed in SJR in Medicine (miscellaneous) and Safety Research with an H index of 74. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 2079 €. The scope of the journal is focused on clinical therapeutics, clinical risk management. It has an SJR impact factor of 0,699 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,699.

ISSN: 1176-6336

Editorial: Dove Medical Press Ltd

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedDOAJ

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guía para Autores (Guidelines)

schedule Datos CoP · solo campos en BD

SJR Impact Factor trending_up

0,699 Q1

H-index 74

Tasa de Aceptación pie_chart

29% Selectiva

Fuente Acceptance_Rate

Tiempo a publicación hourglass_top

16 semanas

Campo Average_time_publication_weeks

Coste de Publicación (APC) payments

2.079 € Open Access

Ruta Non-OA NPD

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR DOAJ

SJR Impact

0,699

H-index

Docs (year)

Docs 3y

322

Total refs

3005

Cites 3y

855

Citable 3y

316

Cites/Doc 2y

2.48

Ref/Doc

35.35

Immediate OA

2079 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Brimonidine in the treatment of glaucoma and ocular hypertension

Willingness-to-pay for caregivers of children with asthma or wheezing conditions

Differential associations between actual and expected GP practice prescribing rates for statins, ACE inhibitors, and beta-blockers: a cross-sectional study in England

Diagnosis and treatment of chronic rhinosinusitis: focus on intranasal Amphotericin B

Depression and drug utilization in an elderly population

Darbepoetin alpha in the treatment of cancer chemotherapy-induced anemia

Dapoxetine, a novel selective serotonin transport inhibitor for the treatment of premature ejaculation

Cost-effectiveness of hypothetical new cancer drugs in patients with advanced small-cell lung cancer: results of a markov chain model

Cost-benefit analysis of influenza vaccination in a public healthcare unit

Comparison of echinocandin antifungals

Clinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4

Clinical implications of changes in hepatic drug metabolism in older people

SHOW MORE ARTICLES

Cancer treatment-induced mucositis pain: strategies for assessment and management

A review of daptomycin for injection (Cubicin) in the treatment of complicated skin and skin structure infections

Bortezomib (Velcade?) in the treatment of multiple myeloma

Azacytidine (Vidaza') in the treatment of myelodysplastic syndromes

An overview of the clinical use of ondansetron in preschool age children

An assessment of the cost-utility of therapy for psoriasis

Alendronate sodium in the management of osteoporosis

Adalimumab in the treatment of arthritis

Acute postoperative pain management: focus on iontophoretic transdermal fentanyl

Acne phototherapy with a 1450-nm diode laser: an open study

Abatacept in the treatment of rheumatoid arthritis

A smarter way to manage asthma with a combination of a long-acting ?2-agonist and inhaled corticosteroid

FAQS

In Country of Papers you can find SJR impact factor and other metrics to help you decide on a Journal.